Ulf Roger Tossman
Directeur/Membre du Conseil chez Novavax AB
Profil
Ulf Roger Tossman is the founder of Coala Life AB, which was founded in 2004.
He held the title of Executive Chairman & Medical Director at Coala Life AB.
Dr. Tossman's current job is as a Director at Novavax AB since 2008.
He is also currently a Director at PBM Sweden AB.
Dr. Tossman's former jobs include being the Chairman of Karessa Pharma Holding AB, a Director at Genizon Biosciences, Inc., a Director at Cellectricon AB, an Investment Director at InnovationsKapital Nordic Advisors AB from 2005 to 2011, a Director at Jolife AB, a Director at Ipsat Therapies Oy, a Director at Recepticon ApS, a Director at Action Pharma A, a Director at Apotek Produktion & Laboratorier AB, a Director at Eskaro Ukraine AB, a Director at Global Medical Investments GMI AB, and a Senior Investment Manager at Swedfund International AB from 2011 to 2016.
Dr. Tossman's education includes a doctorate from Karolinska Institutet.
Postes actifs de Ulf Roger Tossman
| Sociétés | Poste | Début |
|---|---|---|
Novavax AB
 Novavax AB Pharmaceuticals: GenericHealth Technology Novavax AB is engaged in research and development of vaccines. Its products include Matrix and AbiSCO. The company was founded by Bror Morein in 1999 and is headquartered in Uppsala, Sweden. | Directeur/Membre du Conseil | 01/01/2008 |
PBM Sweden AB
 PBM Sweden AB Medical/Nursing ServicesHealth Services PBM Sweden AB offers products and services within Behavioral Psychology. Its treatment, and rehabilitation is based on Cognitive Behavioral Therapy and Behavior-Based Organization. It also provides leadership and organizational development trainings for institutions. The company was founded by Bo von Schéele in 1985 and is headquartered in Stockholm, Sweden. | Directeur/Membre du Conseil | - |
Anciens postes connus de Ulf Roger Tossman
| Sociétés | Poste | Fin |
|---|---|---|
Swedfund International AB
 Swedfund International AB Investment ManagersFinance Swedfund International AB (Swedfund) subsidiary of Government of Sweden is a private equity firm founded in 1979. The firm is headquartered in Stockholm, Sweden. | Private Equity Investor | 30/04/2016 |
Genizon Biosciences, Inc.
 Genizon Biosciences, Inc. BiotechnologyHealth Technology Genizon Biosciences Inc. discovers genes and biomarkers in common diseases using genome wide association studies (GWAS), leveraging its proven and proprietary technology platform and access to patients from the Quebec Founder Population. Genizon has one of the largest GWAS programs worldwide, addressing many common diseases and traits. Several of these have been successfully completed, generating comprehensive maps of interacting genes, biomarkers and biological disease pathways (known as GeneMaps), providing strong validation of the power of the Company's discovery platform. Genizon has out-licensed some of the therapeutic and diagnostic rights to GeneMaps for Crohn's disease (to Genentech) and attention deficit hyperactivity disorder, endometriosis and Alzheimer's disease (disease-state diagnostic rights to Pfizer). GeneMaps have also been generated from GWAS in schizophrenia, psoriasis and longevity. GWAS are in progress for rheumatoid arthritis, Alzheimer's disease, and coronary heart disease and its precursors, obesity, type II diabetes, dyslipidemia and hypertension (collectively metabolic syndrome). Genizon's technology platform and discoveries can complement current R&D programs by using human genetics to significantly enhance research and by adding value at multiple stages of the drug development process. Genizon is continually developing and enhancing its gene and biomarker discovery platform. For example, the company is assessing the role of copy number variations (CNVs) in diseases- applying new methods to ongoing large-scale GWAS in rheumatoid arthritis and metabolic syndrome, and retrospectively to previous studies. Genizon also leverages its platform and expertise by offering high throughput, high quality SNP genotyping, statistical genetics, gene expression and pharmacogenomics services to academic institutions, research organizations and the biopharmaceutical industry. | Directeur/Membre du Conseil | 30/05/2012 |
Ipsat Therapies Oy
 Ipsat Therapies Oy Pharmaceuticals: MajorHealth Technology Ipsat Therapies Oy develops and manufactures antibiotics & drugs. Its products include penicillins, cephalosporins and carbapenems. The firm develops products for the prevention of antibiotic resistance, antibiotic-associated diarrhea and hospital associated infections. The company was founded in 2000 and is headquartered in Helsinki, Finland. | Directeur/Membre du Conseil | 31/01/2012 |
InnovationsKapital Nordic Advisors AB
 InnovationsKapital Nordic Advisors AB Investment ManagersFinance InnovationsKapital Nordic Advisors AB (InnovationsKapital) is a venture capital firm founded in 1994. The firm is headquartered in Gothenburg and Stockholm, Sweden. | Private Equity Investor | 30/09/2011 |
Recepticon ApS
 Recepticon ApS Pharmaceuticals: MajorHealth Technology ReceptIcon is a biotech company based on the identification of novel receptors in the kidney that are responsible for renal uptake and nephrotoxity of therapeutic drugs. The company is focused on the development of receptor antagonists that prevent accumulation of therapeutics in the kidney. Such antagonists can be used as active pharmaceutical ingredients for reformulation of marketed nephrotoxic drugs thereby precluding their toxic side effects. | Directeur/Membre du Conseil | 23/03/2010 |
Formation de Ulf Roger Tossman
| Karolinska Institutet | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Genizon Biosciences, Inc.
Genizon Biosciences, Inc. BiotechnologyHealth Technology Genizon Biosciences Inc. discovers genes and biomarkers in common diseases using genome wide association studies (GWAS), leveraging its proven and proprietary technology platform and access to patients from the Quebec Founder Population. Genizon has one of the largest GWAS programs worldwide, addressing many common diseases and traits. Several of these have been successfully completed, generating comprehensive maps of interacting genes, biomarkers and biological disease pathways (known as GeneMaps), providing strong validation of the power of the Company's discovery platform. Genizon has out-licensed some of the therapeutic and diagnostic rights to GeneMaps for Crohn's disease (to Genentech) and attention deficit hyperactivity disorder, endometriosis and Alzheimer's disease (disease-state diagnostic rights to Pfizer). GeneMaps have also been generated from GWAS in schizophrenia, psoriasis and longevity. GWAS are in progress for rheumatoid arthritis, Alzheimer's disease, and coronary heart disease and its precursors, obesity, type II diabetes, dyslipidemia and hypertension (collectively metabolic syndrome). Genizon's technology platform and discoveries can complement current R&D programs by using human genetics to significantly enhance research and by adding value at multiple stages of the drug development process. Genizon is continually developing and enhancing its gene and biomarker discovery platform. For example, the company is assessing the role of copy number variations (CNVs) in diseases- applying new methods to ongoing large-scale GWAS in rheumatoid arthritis and metabolic syndrome, and retrospectively to previous studies. Genizon also leverages its platform and expertise by offering high throughput, high quality SNP genotyping, statistical genetics, gene expression and pharmacogenomics services to academic institutions, research organizations and the biopharmaceutical industry. | Health Technology |
Cellectricon AB
 Cellectricon AB Miscellaneous Commercial ServicesCommercial Services Cellectricon AB provides cell-based screening services to accelerate drug discovery. The firm develops and validates exciting central nervous system and peripheral pain assays using primary cells, accelerating the path from assay validation to compound screening. Its system is equipped with an imaging-based microplate reader to simultaneously record transient fluorescence and luminescence signals, providing real-time monitoring and readouts of cell culture response. The company was founded by Jan Owe Owesson Orwar, Daniel T. Chiu and Stig Anders Jakob Lindberg in 1999 and is headquartered in Molndal, Sweden. | Commercial Services |
InnovationsKapital Nordic Advisors AB
InnovationsKapital Nordic Advisors AB Investment ManagersFinance InnovationsKapital Nordic Advisors AB (InnovationsKapital) is a venture capital firm founded in 1994. The firm is headquartered in Gothenburg and Stockholm, Sweden. | Finance |
Novavax AB
Novavax AB Pharmaceuticals: GenericHealth Technology Novavax AB is engaged in research and development of vaccines. Its products include Matrix and AbiSCO. The company was founded by Bror Morein in 1999 and is headquartered in Uppsala, Sweden. | Health Technology |
Swedfund International AB
Swedfund International AB Investment ManagersFinance Swedfund International AB (Swedfund) subsidiary of Government of Sweden is a private equity firm founded in 1979. The firm is headquartered in Stockholm, Sweden. | Finance |
Jolife AB
 Jolife AB Medical SpecialtiesHealth Technology Jolife AB develops, manufactures, and markets medical devices. It offers chest compression system for treating sudden cardiac arrest patients with consistent high-quality chest compressions. The firm serves responders, paramedics, and large pre-hospital organizations. The company was founded in 2000 and is headquartered in Lund, Sweden. | Health Technology |
Ipsat Therapies Oy
Ipsat Therapies Oy Pharmaceuticals: MajorHealth Technology Ipsat Therapies Oy develops and manufactures antibiotics & drugs. Its products include penicillins, cephalosporins and carbapenems. The firm develops products for the prevention of antibiotic resistance, antibiotic-associated diarrhea and hospital associated infections. The company was founded in 2000 and is headquartered in Helsinki, Finland. | Health Technology |
Recepticon ApS
Recepticon ApS Pharmaceuticals: MajorHealth Technology ReceptIcon is a biotech company based on the identification of novel receptors in the kidney that are responsible for renal uptake and nephrotoxity of therapeutic drugs. The company is focused on the development of receptor antagonists that prevent accumulation of therapeutics in the kidney. Such antagonists can be used as active pharmaceutical ingredients for reformulation of marketed nephrotoxic drugs thereby precluding their toxic side effects. | Health Technology |
Action Pharma A/S
 Action Pharma A/S BiotechnologyHealth Technology Action Pharma A/S is an R&D-focused biotech company located in the Nordic Medicon Valley area in Copenhagen, Denmark. Action Pharma was founded in 2000 and has a pipeline of 4 drug candidates in different stages of development, plus additional compounds in discovery and early preclinical development. Action Pharma pursues the discovery and development of new drugs and treatment concepts to treat cardiovascular diseases, inflammatory diseases and metabolic diseases, such as type-II diabetes and obesity. Its drug candidates are modified endogenous peptides with improved efficacy and small chemical entities targeted the melanocortin receptors. In disease models, its drug candidates have shown strong effects in treating and preventing inflammation and organ damage in conditions such as post-surgical organ dysfunction and acute myocardial infarction. A major focus for Action Pharma is treatment candidates for type-II diabetes, obesity and metabolic syndrome. Moreover, several drug candidates have shown effects in treating inflammatory diseases, such as rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis and dermatitis. | Health Technology |
Apotek Produktion & Laboratorier AB
 Apotek Produktion & Laboratorier AB Pharmaceuticals: MajorHealth Technology Apotek Produktion & Laboratorier AB develops and manufactures pharmaceutical products. Its services include analytical services, clinical trials and contract manufacturing. The company is headquartered in Kungens Kurva, Sweden. | Health Technology |
PBM Sweden AB
PBM Sweden AB Medical/Nursing ServicesHealth Services PBM Sweden AB offers products and services within Behavioral Psychology. Its treatment, and rehabilitation is based on Cognitive Behavioral Therapy and Behavior-Based Organization. It also provides leadership and organizational development trainings for institutions. The company was founded by Bo von Schéele in 1985 and is headquartered in Stockholm, Sweden. | Health Services |
Eskaro Ukraine AB
 Eskaro Ukraine AB Wholesale DistributorsDistribution Services Eskaro Ukraine AB provides varnish and paint products. It also offers primers, enamel paints, structural materials, oils, varnishes, adhesives, and sealers. The firm’s brands include eskaro, Titan, Condor, KAPRAL, AURA, and GROVER. The company was founded in 2001 and is headquartered in Odessa, Ukraine. | Distribution Services |
Global Medical Investments GMI AB
 Global Medical Investments GMI AB Financial ConglomeratesFinance Global Medical Investments GMI AB establishes and operates cancer centers in developing countries. It engages in the development and support of cancer management programs and cancer treatment clinics. The firm is an investment and project development company. It also secures contracts with health insurance companies and healthcare providers for private and state-run companies and government insurance agencies. The company was founded by Bror Thomas Pollare on July 24, 2009 and is headquartered in Solna, Sweden. | Finance |
Karessa Pharma Holding AB
 Karessa Pharma Holding AB Pharmaceuticals: MajorHealth Technology Karessa Pharma Holding AB engages in the development and commercialization of products in the therapeutic area of erectile dysfunction. Its patented drug is an alignate-based polymer film that is applied to the oral mucosa, which then rapidly delivered out into the bloodstream. The company was founded by Fredrik Hubinette on September 11, 2013 and is headquartered in Taby, Sweden. | Health Technology |
Coala Life AB
 Coala Life AB Medical SpecialtiesHealth Technology Coala-Life AB develops a medical device that connects the person's heart to the cloud, for remote screening and monitoring of heart and lungs. The company was founded by Philip Axel Wilhelm Siberg, Magnus Samuelsson and Ulf Roger Tossman on April 15, 2004 and is headquartered in Stockholm, Sweden. | Health Technology |